|
National Stock Number(NSN): 6505-01-267-1469 (6505012671469, 012671469)
| NIIN: |
01-267-1469 |
Item Name: |
ANTHRALIN OINTMENT |
INC: |
29174
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
29174 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Jun-01-1993 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
LASAN |
24511
|
STIEFEL LABORATORIES, INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
LASAN OINTMENT |
24511
|
STIEFEL LABORATORIES, INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00145-0950-04 |
24511
|
STIEFEL LABORATORIES, INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
Q |
|
1 |
|
$7.09 |
TU |
|
C2201X- |
|
H |
| DF |
JDC |
L |
|
Q |
|
1 |
|
$4.90 |
TU |
|
------N |
|
H |
| DN |
JDC |
L |
|
Q |
|
1 |
|
$7.09 |
TU |
|
9L----- |
|
H |
| DS |
JDC |
L |
|
Q |
|
1 |
|
$7.09 |
TU |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
60GM |
|
|
|
|
| DA |
R |
NOT DMSB STZD |
|
|
|
|
| DF |
K |
60GM |
|
|
|
|
| DF |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DN |
K |
60GM |
|
|
|
|
| DN |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DS |
K |
60GM |
|
|
|
|
| DS |
R |
NON-STD NON-DMSB REV |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
0.400 PERCENTAGE,W/V ANTHRALIN ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
TUBE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
60.000 GRAMS |
| FEAT |
SPECIAL FEATURES |
IN SEALED METAL TUBE |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,STIEFEL LABS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
Z |
|
|
|
|
| FSKX |
|
|
3 |
Z |
|
|
|
|
| N9LM |
|
|
3 |
Z |
|
|
|
|
|